Brief: Aker Biomarine Q1 Adjusted EBITDA At USD 8.1 Million
April 29 (Reuters) - Aker Biomarine ASA AKBM.OL :
* FIRST QUARTER 2022
* Q1 REVENUES OF USD 56.9 MILLION
* Q1 ADJUSTED EBITDA OF USD 8.1 MILLION
* AKER BIOMARINE REITERATES TARGETS FOR 2022
Source text for Eikon: ID:nObidDcXma
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million